Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambisome Preemptive Treatment for Candida in Septic ICU Patients
NCT00697944Phase 4Unknown
- Sponsor
- Fovea Pharmaceuticals
- Start
- Mar 2008
- Primary completion
- Feb 2009
- Countries
- 1
01
Overview
A Phase 4 trial of amphotericin b in candidiasis, sponsored by Fovea Pharmaceuticals. Status: unknown.
02
Drugs
amphotericin b
03
Conditions
candidiasis
Beyond the preview
Go deeper on NCT00697944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697944.